A Super Bowl commercial put out by the telehealth company Hims & Hers is drawing heat from critics who say the company's promotion of its weight-loss drugs misled consumers by leaving out key information.
At the center of the controversy are so-called compounded medications, which aren't regulated in the same way as brand-name or generic drugs are and aren't formally approved by the Food and Drug Administration (FDA).
